|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| New biosensors show how drugs used to treat schizophrenia work. |
|
|
Dec 14, 2009 |
276 |
| Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia. |
|
|
Oct 28, 2009 |
1490 |
| Epilepsy drug could raise schizophrenia risk. |
|
|
Oct 22, 2009 |
242 |
| Schizophrenia drug could beat cancer. |
|
|
Sep 8, 2009 |
116 |
| Schizophrenia drug could beat cancer. |
|
|
Sep 8, 2009 |
120 |
| Injectable beats oral antipsychotics for bipolar. |
McNamara, Damian |
Clinical report |
Sep 1, 2009 |
593 |
| United States : Schering-Plough gets FDA OK for schizophrenia drug. |
|
|
Aug 14, 2009 |
88 |
| Sublingual antipsychotic gets nod from FDA panel: asenapine safe, effective. |
Mechcatie, Elizabeth |
|
Aug 1, 2009 |
661 |
| Schizophrenia drug may help fight cancer. |
|
|
Jun 3, 2009 |
175 |
| HRT can tame mental illness. |
|
|
Jun 2, 2009 |
125 |
| HRT patch aids schizophrenics. |
|
|
May 26, 2009 |
130 |
| 'Singing brains' offer hope for better epilepsy, schizophrenia treatments. |
|
|
May 20, 2009 |
380 |
| Titan Announces FDA Approval of Fanapt[TM] (Iloperidone) For the Treatment of Schizophrenia. |
|
|
May 7, 2009 |
359 |
| ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs. |
|
|
Mar 25, 2009 |
1033 |
| WORLD TODAY: Alzheimer's drugs risk. |
|
|
Jan 9, 2009 |
98 |
| FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment. |
|
|
Oct 9, 2008 |
1608 |
| Off-label Medicine Combinations are Predominant Treatment of Schizophrenics According to PLoS Article. |
|
|
Sep 23, 2008 |
372 |
| Ginkgo biloba and treatment resistant schizophrenia. |
Finney-Brown, Tessa |
|
Sep 22, 2008 |
488 |
| FDA: Some drugs risky for seniors; Antipsychotics used to treat dementia; Medicines now will carry serious warnings. |
|
|
Jun 17, 2008 |
285 |
| BioLineRx Initiates Phase 2b Clinical Trials of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. |
|
|
Jun 12, 2008 |
1109 |
| FDA adds new indications for aripiprazole. |
Osborne, Randall |
|
Jun 1, 2008 |
187 |
| New atypical shows efficacy for inpatients in early trial. |
Henderson, Gina L. |
|
Jun 1, 2008 |
413 |
| ABILIFY(R) (aripiprazole) Receives Expanded Indications for Maintenance Treatment in Both Pediatric Patients (Aged 10-17) With Manic and Mixed Episodes of Bipolar I Disorder and Adolescents (Aged 13-17) With Schizophrenia. |
|
|
May 8, 2008 |
2196 |
| MedImpact Study Highlights the Effects of Restricted Access on Use of Antipsychotic Drugs. |
|
Report |
Apr 29, 2008 |
496 |
| ARYx Therapeutics Enters Clinic with Novel Antipsychotic Drug for Patients with Schizophrenia. |
|
|
Apr 22, 2008 |
1063 |
| Antipsychotic drugs are doing harm. |
|
|
Mar 16, 2008 |
788 |
| Getting the NAC of a novel schizophrenia Tx. |
Jancin, Bruce |
|
Mar 1, 2008 |
725 |
| FDA panel backs longer-lasting Zyprexa. |
|
Brief article |
Feb 12, 2008 |
259 |
| BioLineRx Announces Positive Results From Phase 2a Trial of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. |
|
|
Feb 4, 2008 |
1299 |
| Danger drugs designed for schizophrenics used to calm children of ten; Mischief making: But some GPs prescribe powerful tranquillisers. |
|
|
Nov 12, 2007 |
556 |
| OREXIGEN(TM) Therapeutics to Present Data Supporting Novel, PreClinical Drug Combination for Schizophrenia. |
|
|
Nov 1, 2007 |
242 |
| Elan Announces the Johnson & Johnson Pharmaceutical Research & Development Submission of a New Drug Application to the FDA for Paliperidone Palmitate Using Elan's Proprietary NanoCrystal(R) Technology. |
|
|
Oct 29, 2007 |
720 |
| Lilly adds strong warning label to Zyprexa. |
|
|
Oct 8, 2007 |
635 |
| Indications for risperidone expanded to teens, kids. |
Wachter, Kerri |
|
Sep 1, 2007 |
583 |
| FDA seeks further testing of Wyeth depression drug, deems drug for schizophrenia not approvable. |
|
|
Aug 13, 2007 |
688 |
| CATIE results show overlap of schizophrenia, metabolic disorder. |
Kirn, Timothy F. |
|
Aug 1, 2007 |
435 |
| BioLineRx Initiates Phase II Trial of BL-1020, a First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. |
|
|
Jul 25, 2007 |
737 |
| BioLineRx Initiates a Clinical Receptor-Occupancy Study of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. |
|
|
May 16, 2007 |
643 |
| Antidepressants may benefit prepsychotic teens. |
Splete, Heidi |
|
May 1, 2007 |
330 |
| The depot paradox: long-acting formulations of antipsychotics can boost treatment adherence rates, but clinicians have been hesitant to use them. |
Glazer, William M. |
|
May 1, 2007 |
2199 |
| The importance of early treatment of schizophrenia. |
|
|
Apr 1, 2007 |
2508 |
| ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research. |
|
|
Mar 29, 2007 |
1089 |
| Man treated with controversial acne drug kills himself. |
|
|
Mar 14, 2007 |
553 |
| Weitz & Luxenberg Responds to Study on Off-Label Use of Antipsychotics. |
|
|
Feb 6, 2007 |
488 |
| Line of research could advance schizophrenia Tx. |
Goldman, Erik L. |
|
Feb 1, 2007 |
996 |
| Off-label use of atypicals. |
Schneider, Mary Ellen |
Brief article |
Feb 1, 2007 |
163 |
| Lilly reaches Zyprexa settlement. |
Schneider, Mary Ellen |
Brief article |
Feb 1, 2007 |
169 |
| Omeros Receives up to $9 Million toward Development of Schizophrenia Treatment. |
|
|
Jan 10, 2007 |
470 |
| FDA approves extended-release drug for schizophrenia. |
Walsh, Nancy |
|
Jan 1, 2007 |
386 |
| Schizophrenia, substance use need integrated Tx: take into account the possible synergistic effects between antipsychotics and drugs of abuse. |
Sherman, Carl |
|
Jan 1, 2007 |
1125 |
| New atypical antipsychotic. |
|
|
Jan 1, 2007 |
69 |
| Research and Markets: Market Research available on CNS Drug Discoveries 2006: Schizophrenia. |
|
|
Dec 15, 2006 |
559 |
| Improved monitoring of lipids, glucose needed. |
Walsh, Nancy |
|
Dec 1, 2006 |
431 |
| CUtLASS findings interesting but inconclusive. |
Sullivan, Michele G. |
Clinical report |
Nov 1, 2006 |
758 |
| Data on clozapine augmentation are scarce but do exist. |
Finn, Robert |
|
Aug 1, 2006 |
777 |
| CATIE support of atypical antipsychotics debated. |
Kirn, Timothy F. |
Drug overview |
Jul 1, 2006 |
1209 |
| BioLineRx to Present BL-1020, First in Class Small Molecule for the Treatment of Schizophrenia, at the American Psychiatric Association Annual Meeting. |
|
|
May 18, 2006 |
436 |
| The Market for Typical or Atypical Antipsychotics for the Treatment of Schizophrenia Exceeded $5 Billion in 2005. |
|
|
May 18, 2006 |
515 |
| Clozapine 'wins again' in phase II of CATIE. |
McNamara, Damian |
|
May 1, 2006 |
644 |
| BioLineRx Initiates Phase 1 Clinical Trials of BL-1020, First in Class Small Molecule for the Treatment Of Schizophrenia. |
|
|
Apr 10, 2006 |
515 |
| Placing the risk of diabetes in context: based on an interview with Leslie Citrome, MD, MPH. |
|
Interview |
Apr 1, 2006 |
3685 |
| The cognitive-behavioral treatment of schizophrenia: the state of the art and the evidence. |
Gaudiano, Brandon A. |
|
Mar 22, 2006 |
5535 |
| Olanzapine, haloperidol, and weight. |
Kirn, Timothy F. |
Brief article |
Mar 1, 2006 |
219 |
| Drug combination fails to benefit clozapine-refractory schizophrenia. |
Lowry, Fran |
|
Mar 1, 2006 |
315 |
| Policy making's unintended consequences: line-item management of schizophrenia treatment is not cost-effective. |
Oss, Monica E. |
|
Mar 1, 2006 |
623 |
| The British government is considering increasing the penalties for marijuana possession due to concern over the links between the drug and schizophrenia. |
Carmack, Roberto |
|
Feb 1, 2006 |
56 |
| CATIE renews debate over old versus new antipsychotics: some experts warn against interpreting CATIE's findings as an endorsement of the typicals. |
Enos, Gary A. |
|
Jan 1, 2006 |
1313 |
| Thinking on atypical dosages has changed: survey shows daily dosage of clozapine, risperdone down; trend is upward with olanzapine, quetiapine. |
Sherman, Carl |
|
Jan 1, 2006 |
727 |
| Tapering off medications even with recent-onset schizophrenia a bad idea. |
Melville, Nancy A. |
Statistical data |
Jan 1, 2006 |
495 |
| Medication noncompliance high among Asians with schizophrenia. |
Brunk, Doug |
Brief article |
Jan 1, 2006 |
289 |
| Necessity drives schizophrenia polypharmacy. |
Sherman, Carl |
|
Dec 1, 2005 |
955 |
| Schizophrenia prodrome therapies show promise: early intervention with antipsychotics and CBT appears to delay or prevent psychotic breaks. |
Mahoney, Diana |
|
Oct 1, 2005 |
1314 |
| Study: Old antipsychotic comparable to new drugs. |
|
|
Sep 20, 2005 |
661 |
| Medication compliance vital in schizophrenia Tx. |
MacNeil, Jane Salodof |
|
Aug 1, 2005 |
635 |
| Cognitive side effects of anticholinergics. |
Leard-Hansson, Jan; Guttmacher, Laurence |
|
Aug 1, 2005 |
794 |
| Antipsychotics' effects differ in substance abusers: activation of cytochrome P-450 system by cigarette smoke appears to play a role in drug metabolism. |
McNamara, Damian |
|
Jun 1, 2005 |
533 |
| Dear healthcare professional. |
Lechleiter, John |
|
May 1, 2005 |
424 |
| Important safety information for Zyprexa. |
|
|
May 1, 2005 |
360 |
| Risperidone augmentation of clozapine works! Risperidone augmentation of clozapine doesn't work! A tale of two protocols. |
Citrome, Leslie |
|
May 1, 2005 |
1632 |
| Dear healthcare professional. |
Lechleiter, John |
|
Apr 1, 2005 |
424 |
| Important safety information for Zyprexa. |
|
|
Apr 1, 2005 |
338 |
| Newer antipsychotics, hyperlipidemia. |
Foley, Kevin |
Brief Article |
Mar 1, 2005 |
167 |
| SSRIs for negative symptoms of schizophrenia. |
Leard-Hansson, Jan; Guttmacher, Laurence |
|
Feb 1, 2005 |
771 |
| Clozapine calms aggression. |
Splete, Heidi |
Brief Article |
Feb 1, 2005 |
132 |
| Perspective. |
Bell, Carl C. |
|
Feb 1, 2005 |
352 |
| Anticonvulsants in psychiatry: their similarities are different Part 2--clinical applications. |
Grady, Meghan M. |
|
Feb 1, 2005 |
855 |
| Abilify available as oral solution. |
|
Brief Article |
Feb 1, 2005 |
49 |
| Reducing violence in schizophrenia. |
Foley, Kevin |
Brief Article |
Jan 1, 2005 |
182 |
| Amisulpride's real-world benefit shown in schizophrenia. |
Sullivan, Michele G. |
|
Jan 1, 2005 |
317 |
| Choose atypicals for early onset schizophrenia: two drawbacks are the need for slow titration with younger patients and the high cost of newer agents. |
Walsh, Nancy |
|
Jan 1, 2005 |
908 |
| Online schizophrenia algorithm almost ready: international effort took 3 years to finish. |
Sullivan, Michele G. |
|
Nov 1, 2004 |
538 |
| High-dose ziprasidone effective for treatment-resistant schizophrenia. |
Finn, Robert |
|
Nov 1, 2004 |
437 |
| Reducing clozapine's metabolic side effects. |
Leard-Hansson, Jan; Guttmacher, Laurence |
|
Nov 1, 2004 |
798 |
| Generic schizophrenia drug. |
|
Brief Article |
Oct 1, 2004 |
33 |
| Compliance tougher in schizophrenia. |
McNamara, Damian |
|
Sep 1, 2004 |
692 |
| Depot atypical antipsychotic maintains remission in some. |
Sherman, Carl |
|
Jul 1, 2004 |
474 |
| Amisulpride vs. olanzapine. |
Evans, Jeff |
Brief Article |
Jul 1, 2004 |
132 |
| Risperidone soothes teens' externalizing behavior: compared with olanzapine. |
McNamara, Damian |
|
Nov 1, 2003 |
381 |
| Use caution when adding Rx to atypicals: augmenting psychotropics ill advised. (another antipsychotic drug). |
Sherman, Carl |
|
Oct 1, 2003 |
542 |
| Antipsychotic weight gain. |
Evans, Jeff |
Brief Article |
Oct 1, 2003 |
131 |
|
